CAPELLO JEFFREY D — SEC Form 4 filings
SEC reporting owner CIK 1224108. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-17 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 20,712 shares, $100,217 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
- Largest priced transaction: purchase of 20,712 shares @ $4.84 ($100,217) in NEOGEN CORP, filed 2025-04-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEOGEN CORP (NEOG) | Director | 8 | 1 leg · 20,712 sh · $100,217 | — | 14 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | Director | 6 | — | — | 16 |
Form 4 filings — CAPELLO JEFFREY D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,816 @ $0 · Option exercise (M): 2,816 (derivative) @ $0 · Grant/award (A): 2,927 (derivative) @ $0 · Grant/award (A): 14,950 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 1,976 @ $0 · Option exercise (M): 1,976 (derivative) @ $0 | EDGAR |
| 2025-10-29 | 4 | NEOGEN CORP (NEOG) | Option exercise (M): 1,777 @ $6.19 · Option exercise (M): 1,777 (derivative) @ $6.19 | EDGAR |
| 2025-10-28 | 4 | NEOGEN CORP (NEOG) | Option exercise (M): 2,025 @ $6.19 · Option exercise (M): 2,025 (derivative) @ $6.19 | EDGAR |
| 2025-10-27 | 4 | NEOGEN CORP (NEOG) | Grant/award (A): 19,769 @ $6.07 · Grant/award (A): 50,814 (derivative) @ $0 | EDGAR |
| 2025-10-09 | 4 | NEOGEN CORP (NEOG) | Option exercise (M): 2,071 @ $5.63 · Option exercise (M): 2,071 (derivative) @ $5.63 | EDGAR |
| 2025-06-23 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 2,120 @ $0 · Grant/award (A): 2,861 (derivative) @ $0 · Grant/award (A): 15,768 (derivative) @ $0 · Option exercise (M): 2,120 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 1,977 @ $0 · Option exercise (M): 1,977 (derivative) @ $0 | EDGAR |
| 2025-04-22 | 4 | NEOGEN CORP (NEOG) | Purchase (P): 20,712 @ $4.84 | EDGAR |
| 2024-10-29 | 4 | NEOGEN CORP (NEOG) | Option exercise (M): 1,776 @ $13.81 · Option exercise (M): 1,776 (derivative) @ $13.81 | EDGAR |
| 2024-10-28 | 4 | NEOGEN CORP (NEOG) | Grant/award (A): 6,075 @ $13.58 · Grant/award (A): 18,653 (derivative) @ $0 | EDGAR |
| 2024-10-09 | 4 | NEOGEN CORP (NEOG) | Option exercise (M): 2,070 @ $15.07 · Option exercise (M): 2,070 (derivative) @ $15.07 | EDGAR |
| 2024-06-24 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/award (A): 2,120 (derivative) @ $0 · Grant/award (A): 11,774 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Option exercise (M): 1,976 @ $0 · Option exercise (M): 1,976 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1224108 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →